Literature DB >> 34298736

Cancer-Associated Fibroblasts: Implications for Cancer Therapy.

Ana Maia1, Stefan Wiemann1.   

Abstract

Tumour cells do not exist as an isolated entity. Instead, they are surrounded by and closely interact with cells of the environment they are emerged in. The tumour microenvironment (TME) is not static and several factors, including cancer cells and therapies, have been described to modulate several of its components. Fibroblasts are key elements of the TME with the capacity to influence tumour progression, invasion and response to therapy, which makes them attractive targets in cancer treatment. In this review, we focus on fibroblasts and their numerous roles in the TME with a special attention to recent findings describing their heterogeneity and role in therapy response. Furthermore, we explore how different therapies can impact these cells and their communication with cancer cells. Finally, we highlight potential strategies targeting this cell type that can be employed for improving patient outcome.

Entities:  

Keywords:  cancer associated fibroblast (CAF); cell communication; signalling; therapy resistance; tumour microenvironment (TME)

Year:  2021        PMID: 34298736     DOI: 10.3390/cancers13143526

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

1.  Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems.

Authors:  Yi Wei; Bastian Amend; Tilman Todenhöfer; Nizar Lipke; Wilhelm K Aicher; Falko Fend; Arnulf Stenzl; Niklas Harland
Journal:  Int J Mol Sci       Date:  2022-06-04       Impact factor: 6.208

Review 2.  Tumor metastasis: Mechanistic insights and therapeutic interventions.

Authors:  Mengmeng Liu; Jing Yang; Bushu Xu; Xing Zhang
Journal:  MedComm (2020)       Date:  2021-12-02

3.  Neoadjuvant Chemotherapy of Patients with Early Breast Cancer Is Associated with Increased Detection of Disseminated Tumor Cells in the Bone Marrow.

Authors:  Léa Volmer; André Koch; Sabine Matovina; Dominik Dannehl; Martin Weiss; Ganna Welker; Markus Hahn; Tobias Engler; Markus Wallwiener; Christina Barbara Walter; Ernst Oberlechner; Sara Yvonne Brucker; Klaus Pantel; Andreas Hartkopf
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

Review 4.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

5.  Potential of Gold Nanoparticle in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblast Cells.

Authors:  Abdulaziz Alhussan; Nicholas Palmerley; Julian Smazynski; Joanna Karasinska; Daniel J Renouf; David F Schaeffer; Wayne Beckham; Abraham S Alexander; Devika B Chithrani
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

6.  Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.

Authors:  Lea Monteran; Nour Ershaid; Hila Doron; Yael Zait; Ye'ela Scharff; Shahar Ben-Yosef; Camila Avivi; Iris Barshack; Amir Sonnenblick; Neta Erez
Journal:  Nat Commun       Date:  2022-10-02       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.